148 related articles for article (PubMed ID: 31342478)
1. Effect of Exercise on Outcome after Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Müssigbrodt A; Czimbalmos C; Stauber A; Bertagnolli L; Bode K; Dagres N; Döring M; Richter S; Sommer P; Husser D; Bollmann A; Hindricks G; Arya A
Int J Sports Med; 2019 Sep; 40(10):657-662. PubMed ID: 31342478
[TBL] [Abstract][Full Text] [Related]
2. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation?
Müssigbrodt A; Efimova E; Knopp H; Bertagnolli L; Dagres N; Richter S; Husser D; Bollmann A; Hindricks G; Arya A
J Interv Card Electrophysiol; 2017 Mar; 48(2):193-199. PubMed ID: 27900527
[TBL] [Abstract][Full Text] [Related]
3. Supraventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy associate with long-term outcome after catheter ablation of ventricular tachycardias.
Müssigbrodt A; Knopp H; Efimova E; Weber A; Bertagnolli L; Hilbert S; Kosiuk J; Dinov B; Bode K; Kircher S; Dagres N; Richter S; Sommer P; Husser D; Bollmann A; Hindricks G; Arya A
Europace; 2018 Jul; 20(7):1182-1187. PubMed ID: 28595345
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
[TBL] [Abstract][Full Text] [Related]
5. Myocardial voltage ratio in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Müssigbrodt A; Bertagnolli L; Efimova E; Kosiuk J; Dinov B; Bode K; Kircher S; Dagres N; Döring M; Richter S; Sommer P; Husser D; Bollmann A; Hindricks G; Arya A
Herzschrittmacherther Elektrophysiol; 2017 Jun; 28(2):219-224. PubMed ID: 28536891
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Dalal D; Jain R; Tandri H; Dong J; Eid SM; Prakasa K; Tichnell C; James C; Abraham T; Russell SD; Sinha S; Judge DP; Bluemke DA; Marine JE; Calkins H
J Am Coll Cardiol; 2007 Jul; 50(5):432-40. PubMed ID: 17662396
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE
Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Philips B; Madhavan S; James C; Tichnell C; Murray B; Dalal D; Bhonsale A; Nazarian S; Judge DP; Russell SD; Abraham T; Calkins H; Tandri H
Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):499-505. PubMed ID: 22492430
[TBL] [Abstract][Full Text] [Related]
9. The application of signal average ECG in the prediction of recurrences after catheter ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Liao YC; Chung FP; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang YT; Hsieh MH; Chen SA
Int J Cardiol; 2017 Jun; 236():168-173. PubMed ID: 28131707
[TBL] [Abstract][Full Text] [Related]
10. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Chung FP; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Chiou CW; Chen SA
J Cardiol; 2015 Jun; 65(6):441-50. PubMed ID: 25818480
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: Insights from the Johns Hopkins ARVC Program.
Daimee UA; Assis FR; Murray B; Tichnell C; James CA; Calkins H; Tandri H
Heart Rhythm; 2021 Aug; 18(8):1369-1376. PubMed ID: 33933674
[TBL] [Abstract][Full Text] [Related]
12. Precordial QRS amplitude ratio predicts long-term outcome after catheter ablation of electrical storm due to ventricular tachycardias in patients with arrhythmogenic right ventricular cardiomyopathy.
Müssigbrodt A; Dinov B; Bertagnoli L; Sommer P; Richter S; Breithardt OA; Rolf S; Bollmann A; Hindricks G; Arya A
J Electrocardiol; 2015; 48(1):86-92. PubMed ID: 25465865
[TBL] [Abstract][Full Text] [Related]
13. Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy.
Laredo M; Oliveira Da Silva L; Extramiana F; Lellouche N; Varlet É; Amet D; Algalarrondo V; Waintraub X; Duthoit G; Badenco N; Maupain C; Hidden-Lucet F; Maury P; Gandjbakhch E;
Heart Rhythm; 2020 Jan; 17(1):41-48. PubMed ID: 31284048
[TBL] [Abstract][Full Text] [Related]
14. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.
Souissi Z; Boulé S; Hermida JS; Doucy A; Mabo P; Pavin D; Anselme F; Auquier N; Ninni S; Coisne A; Brigadeau F; Deken-Delannoy V; Klug D; Lacroix D
Europace; 2018 Feb; 20(2):362-369. PubMed ID: 28017936
[TBL] [Abstract][Full Text] [Related]
15. Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia.
Ellison KE; Friedman PL; Ganz LI; Stevenson WG
J Am Coll Cardiol; 1998 Sep; 32(3):724-8. PubMed ID: 9741518
[TBL] [Abstract][Full Text] [Related]
16. Endo/epicardial ablation of ventricular arrhythmias with contact force-sensing catheters in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Aras D; Özcan F; Çay S; Özeke Ö; Kara M; Topaloğlu S
Anatol J Cardiol; 2019 Mar; 21(4):187-195. PubMed ID: 30930451
[TBL] [Abstract][Full Text] [Related]
17. Catheter ablation of arrhythmogenic right ventricular cardiomyopathy ventricular tachycardia: 18-year experience in 284 patients.
Liang E; Wu L; Fan S; Hu F; Zheng L; Liu S; Fan X; Chen G; Ding L; Niu G; Yao Y
Europace; 2020 May; 22(5):806-812. PubMed ID: 32155249
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia.
Verma A; Kilicaslan F; Schweikert RA; Tomassoni G; Rossillo A; Marrouche NF; Ozduran V; Wazni OM; Elayi SC; Saenz LC; Minor S; Cummings JE; Burkhardt JD; Hao S; Beheiry S; Tchou PJ; Natale A
Circulation; 2005 Jun; 111(24):3209-16. PubMed ID: 15956125
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia.
Pokushalov E; Romanov A; Turov A; Artyomenko S; Shirokova N; Karaskov A
Heart Rhythm; 2010 Oct; 7(10):1406-10. PubMed ID: 20601157
[TBL] [Abstract][Full Text] [Related]
20. Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD- A propensity matched analysis.
Bandyopadhyay D; Sahoo D; Zein J; Brunken RC; Tchou PJ; Culver DA
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):70-9. PubMed ID: 26237358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
